Josh Forsythe Apr 21, 2015 Save for later Josh Forsythe has joined Tute Genomics as VP of marketing. Prior to Tute, Forsythe held executive sales and marketing positions at Golden Helix and Knome. Breaking News TwinStrand Biosciences Raises $50M in Series B Round Becton Dickinson Fiscal Q2 Revenues up 15 Percent Bio-Techne Fiscal Q3 Revenues Rise 25 Percent as End Markets Improve Quanterix Q1 Revenues up 73 Percent OraSure Technologies Q1 Revenues Jump 85 Percent 10x Genomics Q1 Revenues Jump 47 Percent The Scan US Supports Patent Waivers NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines. Vaccines Versus Variants Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants. CRISPR for What Ails You The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks. Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants In Nature this week: review of ways to integrate data from single-cell assays, and more.